ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
Phospholipase A2 downregulates inhibitory transmission in the amygdala and impairs fear extinction.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Dysregulated phospholipase A2 (PLA2) activity has been reported in multiple psychiatric disorders, yet its mechanistic contribution to pathological fear remains unclear. The 129S1/SvImJ (S1) mouse strain, which shows intact fear conditioning but profound deficits in fear extinction, provides a useful model for examining molecular pathways relevant to post-traumatic stress disorder. Using RNA sequencing, electrophysiology, and targeted pharmacological manipulation, we investigated whether altered PLA2 expression in amygdala circuits contributes to impaired extinction in S1 mice. S1 mice displayed markedly elevated Pla2g4e mRNA expression in both the basolateral amygdala (BLA) and the medial division of the central amygdala (CEm) compared with C57BL/6 controls. Electrophysiological analyses revealed reduced basal inhibitory transmission onto CEm neurons in S1, a deficit reversed by acute PLA2 inhibition in both naïve and behaviorally tested mice. PLA2 inhibition also normalized the diminished inhibitory/excitatory balance in the BLA→CEm pathway following extinction training. Behaviorally, selective infusion of a PLA2 inhibitor into the CEm robustly enhanced extinction learning and retrieval in S1mice. These findings identify PLA2 as a key regulator of inhibitory signaling within central amygdala circuits and suggest that heightened PLA2 activity contributes to extinction failure, highlighting a potential molecular target for therapeutic intervention in trauma-related disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.